(1S,2S,3R,4R)-3-[2-(4-(morpholin-4-yl)methylphenyl)-3H-imidazo[4,5-b]pyridin-7-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide | 1449503-04-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (1S,2S,3R,4R)-3-[2-(4-(morpholin-4-yl)methylphenyl)-3H-imidazo[4,5-b]pyridin-7-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide
• 英文别名: (1S,2S,3R,4R)-3-[2-(4-Morpholin-4-ylmethyl-phenyl)-3H-imidazo[4,5-b]pyridin-7-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide；(1S,2S,3R,4R)-3-[[2-[4-(morpholin-4-ylmethyl)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide
• CAS: 1449503-04-1
• 化学式: C₂₅H₂₈N₆O₂
• 分子量: 444.536
• InChiKey: WZFAKHGXPTVJOG-YXYSEUPNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  33
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  109
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  (1S,2S,3R,4R)-3-(2,3-Diamino-pyridin-4-ylamino)-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide 、 4-吗啉甲基苯甲醛 以to produce 27 mg (32%) of the title compound的产率得到(1S,2S,3R,4R)-3-[2-(4-(morpholin-4-yl)methylphenyl)-3H-imidazo[4,5-b]pyridin-7-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide
  参考文献：
  名称：

  Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders

  摘要：

  本申请涉及公式I所定义的化合物和/或其盐。本申请还涉及使用这些化合物和/或其盐的组合物和方法。公式I的化合物可用作ALK和JAK调节剂，用于治疗增生性疾病。

  公开号：

  US20140350011A1

文献信息

• [EN] IMIDAZO [4, 5 - B] PYRIDINE DERIVATIVES AS ALK AND JAK MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS<br/>[FR] DÉRIVÉS IMIDAZO [4,5-B] PYRIDINE COMME MODULATEURS D'ALK ET DE JAK POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS
  申请人：CEPHALON INC

  公开号：WO2013116291A1

  公开（公告）日：2013-08-08

  This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.

  这项申请涉及到本文所定义的Formula I化合物及/或其盐。此申请进一步涉及到使用这些化合物和/或其盐的组合物和方法。Formula I化合物可用作ALK和JAK调节剂，用于治疗增殖性疾病。
• Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders
  申请人：Cephalon, Inc.

  公开号：US09238656B2

  公开（公告）日：2016-01-19

  This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.

  本申请涉及公式I所定义的化合物及/或其盐。本申请还涉及使用这些化合物和/或其盐的组合物和方法。公式I的化合物可用作ALK和JAK调节剂，用于治疗增殖性疾病。
• IMIDAZO [4, 5 - B]PYRIDINE DERIVATIVES AS ALK AND JAK MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
  申请人：Cephalon, Inc.

  公开号：EP2809671B1

  公开（公告）日：2016-01-13
• US9238656B2
  申请人：——

  公开号：US9238656B2

  公开（公告）日：2016-01-19